NPL and NML are part of the UK National Measurement System, delivering world-class measurement science and technology and providing traceable and increasingly accurate standards of measurement. Their expertise includes high quality measurement research using a range of approaches to improve the safety and efficacy of advanced therapeutics. The Innovate UK funded collaboration, which officially started on the 1st March 2020, enables Sixfold to access their state-of-the-art technologies, facilities and expertise.

Sixfold Bioscience Ltd.

Sixfold Bioscience is a venture-backed preclinical-stage biotechnology company based at the Innovation and Translation Hub in White City, London. Sixfold develops nucleic acid-based drug delivery systems, with a current focus on Cell & Gene therapeutics such as short interfering RNA for gene silencing and messenger RNA for gene expression. For more information, visit: https://www.sixfold.bio

‍

Innovate UK

Innovate UK is a government-funded public body, part of UK Research & Innovation — supporting business growth & development, and in particular the development and realisation of fresh ideas. Since 2007, IUK has invested ~£2.5 billion to help businesses across the country, and in combination with industry funding, the total value of projects has amounted to over £4.3 billion as of 2019. For more information, visit: www.innovateuk.ukri.org

‍